Glutathione S-transferases related to P. aeruginosa lung infection in cystic fibrosis children: Preliminary study

Clinical Biochemistry

Volumn 42, Issue 1-2, 2009, Pages 57-63

  Feuillet Fieux, Marie Noëlle ^a   Nguyen Khoa, Thao ^a   Loriot, Marie Anne ^b,c   Kelly, Mairead ^a   de Villartay, Philippe ^a   Sermet, Isabelle ^a   Verrier, Patricia ^a   Bonnefont, Jean Paul ^a   Beaune, Philippe ^b,c   Lenoir, Gérard ^a   Lacour, Bernard ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c INSERM   (France)

Author keywords

Cystic fibrosis; Glutathione S transferase; Lung infection; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; GENOMIC DNA; GLUTATHIONE; GLUTATHIONE TRANSFERASE; RETINOL;

ADOLESCENT; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; ENZYME ACTIVITY; ERYTHROCYTE LEVEL; FEMALE; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LUNG INFECTION; MALE; OXIDATIVE STRESS; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPECTROPHOTOMETRY;

ADOLESCENT; ASCORBIC ACID; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTIC FIBROSIS; ERYTHROCYTES; FEMALE; GENOTYPE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; VITAMIN A; VITAMIN E; YOUNG ADULT;

EID: 57649106997     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.09.116     Document Type: Article

References (38)

1. Watson M.A., Stewart R.K., Smith G.B., Massey T.E., and Bell D.A. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19 (1998) 275-280
2. Linsdell P., Hanrahan, and J.W. Glutathione permeability of CFTR. Am. J. Physiol. 275 (1998) C323-C326
3. Gao L., Kim K.J., Yankaskas J.R., and Forman H.J. Abnormal glutathione transport in cystic fibrosis airway epithelia. Am. J. Physiol. 277 (1999) L113-L118
4. Childers M., Eckel G., Himmel A., and Caldwell J. A new model of cystic fibrosis pathology: lack of transport of glutathione and its thiocyanate conjugates. Med. Hypotheses 68 (2007) 101-112
5. Bishop M.D., Freedman S.D., Zielenski J., et al. The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis. Hum. Genet. 118 (2005) 372-381
6. Blackman S.M., Deering-Brose R., McWilliams R., et al. Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis. Gastroenterology 131 (2006) 1030-1039
7. Bateman N.D., Fahy C., and Woolford T.J. Nasal polyps: still more questions than answers. J. Laryngol. Otol. 117 (2003) 1-9
8. Nakamura C.T., Ng G.Y., Paton J.Y., et al. Correlation between digital clubbing and pulmonary function in cystic fibrosis. Pediatr. Pulmonol. 33 (2002) 332-338
9. Nguyen-Khoa T., Massy Z.A., De Bandt J.P., et al. Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment. Nephrol. Dial. Transplant. 16 (2001) 335-340
10. Fumeron C., Nguyen-Khoa T., Saltiel C., et al. Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients. Nephrol. Dial. Transplant. 20 (2005) 1874-1879
11. Habig W.H., Pabst M.J., and Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249 (1974) 7130-7139
12. Habdous M., Vincent-Viry M., Visvikis S., and Siest G. Rapid spectrophotometric method for serum glutathione S-transferases activity. Clin. Chim. Acta 326 (2002) 131-142
13. Harris M.J., Coggan M., Langton L., Wilson S.R., and Board P.G. Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics 8 (1998) 27-31
14. Nedelcheva Kristensen V., Andersen T.I., Erikstein B., et al. Single tube multiplex polymerase chain reaction genotype analysis of GSTM1, GSTT1 and GSTP1: relation of genotypes to TP53 tumor status and clinicopathological variables in breast cancer patients. Pharmacogenetics 8 (1998) 441-447
15. Back E.I., Frindt C., Nohr D., et al. Antioxidant deficiency in cystic fibrosis: when is the right time to take action?. Am. J. Clin. Nutr. 80 (2004) 374-384
16. Rosenecker J. Relations between the frequency of the DeltaF 508 mutation and the course of pulmonary disease in cystic fibrosis patients infected with Pseudomonas aeruginosa. Eur. J. Med. Res. 5 (2000) 356-359
17. Gannage-Yared M.H., Khneisser I., Salem N., et al. Blood and leukocyte glutathione and glutathione S-transferase: relationship to cholesterolemia in healthy volunteers. Ann. Biol. Clin. (Paris) 56 (1998) 321-327
18. Howie A.F., Forrester L.M., Glancey M.J., et al. Glutathione S-transferase and glutathione peroxidase expression in normal and tumour human tissues. Carcinogenesis 11 (1990) 451-458
19. Sweeney C., Nazar-Stewart V., Stapleton P.L., Eaton D.L., and Vaughan T.L. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients. Cancer Epidemiol. Biomark. Prev. 12 (2003) 527-533
20. Carmagnol F., Sinet P.M., Rapin J., and Jerome H. Glutathione-S-transferase of human red blood cells; assay, values in normal subjects and in two pathological circumstances: hyperbilirubinemia and impaired renal function. Clin. Chim. Acta 117 (1981) 209-217
21. Massaad-Massade L., Ribrag V., Marie J.P., et al. Glutathione system, topoisomerase II level and multidrug resistance phenotype in acute myelogenous leukemia before treatment and at relapse. Anticancer Res. 17 (1997) 4647-4651
22. Gronau S., Koenig-Greger D., Jerg M., and Riechelmann H. GSTM1 enzyme concentration and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity. Oral Dis. 9 (2003) 62-67
23. Habif S., Mutaf I., Turgan N., et al. Age and gender dependent alterations in the activities of glutathione related enzymes in healthy subjects. Clin. Biochem. 34 (2001) 667-671
24. Lagrange-Puget M., Durieu I., Ecochard R., et al. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation. Pediatr. Pulmonol. 38 (2004) 43-49
25. Prousky J. The treatment of pulmonary diseases and respiratory-related conditions with inhaled (nebulized or aerosolized) glutathione. Evid. Based Complement. Alternat. Med. 5 (2008) 27-35
26. *)
27. Hull J., and Thomson A.H. Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. Thorax 53 (1998) 1018-1021
28. Baranov V.S., Ivaschenko T., Bakay B., et al. Proportion of the GSTM1 0/0 genotype in some Slavic populations and its correlation with cystic fibrosis and some multifactorial diseases. Hum. Genet. 97 (1996) 516-520
29. Hayes J.D., and Strange R.C. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61 (2000) 154-166
30. Brasch-Andersen C., Christiansen L., Tan Q., Haagerup A., Vestbo J., and Kruse T.A. Possible gene dosage effect of glutathione-S-transferases on atopic asthma: using real-time PCR for quantification of GSTM1 and GSTT1 gene copy numbers. Hum. Mutat. 24 (2004) 208-214
31. He J.Q., Ruan J., Connett J.E., Anthonisen N.R., Pare P.D., and Sandford A.J. Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am. J. Respir. Crit. Care Med. 166 (2002) 323-328
32. Rodriguez F., de la Roza C., Jardi R., Schaper M., Vidal R., and Miravitlles M. Glutathione S-transferase P1 and lung function in patients with alpha1-antitrypsin deficiency and COPD. Chest 127 (2005) 1537-1543
33. Fryer A.A., Bianco A., Hepple M., Jones P.W., Strange R.C., and Spiteri M.A. Polymorphism at the glutathione S-transferase GSTP1 locus. A new marker for bronchial hyperresponsiveness and asthma. Am. J. Respir. Crit. Care Med. 161 (2000) 1437-1442
34. Henrion-Caude A., Flamant C., Roussey M., et al. Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism. Hepatology 36 (2002) 913-917
35. Mitrunen K., Jourenkova N., Kataja V., et al. Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol. Biomark. Prev. 10 (2001) 229-236
36. Harries L.W., Stubbins M.J., Forman D., Howard G.C., and Wolf C.R. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18 (1997) 641-644
37. Flamant C., Henrion-Caude A., Boelle P.Y., et al. Glutathione-S-transferase M1, M3, P1 and T1 polymorphisms and severity of lung disease in children with cystic fibrosis. Pharmacogenetics 14 (2004) 295-301
38. Drumm M.L., Konstan M.W., Schluchter M.D., et al. Genetic modifiers of lung disease in cystic fibrosis. N. Engl. J. Med. 353 (2005) 1443-1453